Patents by Inventor Mohammad Rafeeq

Mohammad Rafeeq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210122777
    Abstract: A process for preparing ketolide compounds is disclosed.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 29, 2021
    Applicant: WOCKHARDT LIMITED
    Inventors: Furqan Mohammed DIWAN, Amit PUND, Mohammad RAFEEQ, Arvind Yekanathsa MERWADE
  • Patent number: 7566782
    Abstract: The present invention relates to a process for the preparation of rosuvastatin calcium, a promising new HMG-CoA reductase inhibitor.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: July 28, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Hashim Nizar Poovanathil Nagoor Meeran, Shantanu De, Mohammad Rafeeq, Swargam Sathyanarayana
  • Publication number: 20090036680
    Abstract: The present invention relates to salts of HMG CoA reductase inhibitors, and in particular, rosuvastatin amine salts and their use as intermediates in the preparation of rosuvastatin calcium.
    Type: Application
    Filed: January 19, 2005
    Publication date: February 5, 2009
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Yatendra Kumar, Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana
  • Publication number: 20080234302
    Abstract: Provided are processes for preparing amorphous rosuvastatin calcium from crystalline rosuvastatin calcium by simple precipitation processes. Also provided is a novel polymorphic form of rosuvastatin sodium, processes for preparing thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 20, 2005
    Publication date: September 25, 2008
    Inventors: Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana, Yatendra Kumar
  • Publication number: 20070244144
    Abstract: The present invention relates to an improved process for the preparation of Form 1 of desloratadine essentially free of Form 2. The invention also relates to Form 1 of desloratadine substantially free of Form 2, process for its preparation, pharmaceutical composition comprising it and its method of use for the treatment of allergic reactions in mammals.
    Type: Application
    Filed: April 10, 2007
    Publication date: October 18, 2007
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Deepak MURPANI, Mohammad RAFEEQ, Praveen RAHEJA, Swargam SATHYANARAYANA, Mohan PRASAD
  • Publication number: 20070191318
    Abstract: The invention relates to processes for the preparation of amorphous rosuvastatin calcium. More particularly, it relates to the preparation of pure amorphous rosuvastain calcium and pharmaceutical compositions that include the pure amorphous rosuvastatin calcium. The invention also relates to use of said compositions for treating hyperlipidemia, hypercholesterolemia, and atherosclerosis. Formula (I).
    Type: Application
    Filed: October 22, 2004
    Publication date: August 16, 2007
    Inventors: Yatendra Kumar, Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana
  • Publication number: 20050222415
    Abstract: The present invention relates to a cost effective and industrially advantageous process for the preparation of 4-4(fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulphonylamino)-5-pyrimidinecarboxaldehyde, referred to here as pyrimidine aldehyde of structural Formula I and to the use of this compound as intermediate for the preparation of rosuvastatin.
    Type: Application
    Filed: May 21, 2003
    Publication date: October 6, 2005
    Inventors: Yatendra Kumar, Shantanu De, Mohammad Rafeeq, Hashim Nizar Poovanathil Meeran, Swargam Sathyanarayana